CLINICAL_TRIALS
trial_result
· 2012-08-08
Clinical Trial Update: Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting Stent [Phase 4]
Summary
A Phase 4 clinical trial evaluating valsartan for suppression of plaque volume and restenosis after a drug-eluting stent in coronary artery disease has complete…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Seung-Jung Park | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED